Found 44 articles for: "Carcinoma"
Evaluating the Clinical Efficacy, Utility, and Role of the 40-Gene Expression Profiling Test in Assessing Prognosis of Cutaneous Squamous Cell Carcinoma: An Expert Consensus Panel
November 2026 | Volume 25 | Issue 11 | Original Article | 1051 | Copyright © November 2026
Background: The 40-gene expression profiling (40-GEP) test has been validated to identify patients at highest risk for nodal or distant metastasis, as well as those most likely t...
Read MoreCelecoxib, Sirolimus, and Acitretin are Associated With Decreased Non-Melanoma Skin Cancer in the General Population
November 2026 | Volume 25 | Issue 11 | Editorials | 1077 | Copyright © November 2026
Can't Believe It Can Be Cryo'd: Beyond Conventional Applications of Liquid Nitrogen
October 2026 | Volume 25 | Issue 10 | Features | 981 | Copyright © October 2026
Pigmented Basal Cell Carcinoma in Skin of Color: A Systematic Review of the Literature
July 2026 | Volume 25 | Issue 7 | Original Article | 605 | Copyright © July 2026
Background: Though basal cell carcinoma (BCC) is most often studied in Fitzpatrick Skin Types (FST) I-III, BCC in skin of color (SOC) is characterized by unique clinical features...
Read MoreTrends in Fluorouracil and Calcipotriene Utilization for Actinic Keratosis
June 2026 | Volume 25 | Issue 6 | Editorials | e56 | Copyright © June 2026
Predicting Benefit of Adjuvant Radiation Therapy for Cutaneous Squamous Cell Carcinoma: A Systematic Review
June 2026 | Volume 25 | Issue 6 | Original Article | 502 | Copyright © June 2026
Background: Cutaneous squamous cell carcinoma (cSCC) is the second most prevalent skin cancer, and its incidence has been rising.Certain patients with high-risk cSCC...
Read MoreEfficacy and Safety of Cosibelimab for Advanced Cutaneous Squamous Cell Carcinoma: An Expert Consensus Panel
May 2026 | Volume 25 | Issue 5 | Original Article | 413 | Copyright © May 2026
Background: Cutaneous squamous cell carcinoma (cSCC) represents a significant clinical challenge in patients with locally advanced (laCSCC) or metastatic (mCSCC) disease who are ...
Read MoreSafety and Efficacy of Aminolevulinic Acid 20% Topical Solution Activated by Blue Light for Facial Cutaneous Squamous Cell Carcinoma in situ
May 2026 | Volume 25 | Issue 5 | Original Article | 454 | Copyright © May 2026
Background: Squamous cell carcinoma in situ (isSCC) is an early-stage cutaneous malignancy that requires effective treatment to prevent progression to invasive SCC. Aminolevulini...
Read MoreEfficacy and Safety of Topical Metformin vs Kligman Formula in the Treatment of Melasma: A Split-Face Study
May 2026 | Volume 25 | Issue 5 | Original Article | 435 | Copyright © May 2026
Background: Melasma is an acquired pigmentary disorder characterized by symmetrical hyperpigmented macules and patches on sun-exposed areas, primarily the face. Kligman's formula...
Read MoreThe Emerging Role of Metformin in Skin Cancer: Mechanistic and Clinical Insights
May 2026 | Volume 25 | Issue 5 | Original Article | 444 | Copyright © May 2026
Background: Metformin, widely used for type 2 diabetes mellitus, has demonstrated antitumor effects through modulation of metabolic and immune pathways. This review explores its ...
Read MoreMalignancy Risk in Autoimmune Blistering Disorders: A Retrospective Cohort Study
May 2026 | Volume 25 | Issue 5 | Editorials | e47 | Copyright © May 2026
Increased Odds of Multiple Primary Cancers in Merkel Cell Carcinoma Patients: A Large-Scale Propensity-Matched Analysis
August 2025 | Volume 24 | Issue 8 | Editorials | e51 | Copyright © August 2025
Current Use of Neoadjuvant Hedgehog Inhibitors Among Mohs Surgeons: Results of a Cross-Sectional Survey
July 2025 | Volume 24 | Issue 7 | Features | 722 | Copyright © July 2025
Recent studies have demonstrated functional and cosmetic benefits with the use of hedgehog pathway inhibitors in the neoadjuvant setting for basal cell carcinoma (BCC). This study investigated th...
Read MoreClinical Features and the Management of Drug-Induced Eruptive Keratoacanthoma and Squamous Cell Carcinoma: A Review of 172 Cases
May 2025 | Volume 24 | Issue 5 | Original Article | 476 | Copyright © May 2025
Background: The sudden appearance of keratoacanthomas (KA) and squamous cell carcinomas (SCC) is a serious complication of several oncologic and immunomodulatory medications. The...
Read MoreEfficacy and Safety of Hedgehog Inhibitors for Advanced Basal Cell Carcinoma: An Expert Consensus Panel
May 2025 | Volume 24 | Issue 5 | Original Article | 465 | Copyright © May 2025
Background: Hedgehog inhibitors (HHIs) can be used to treat patients with locally advanced basal cell carcinoma (laBCC) who are not candidates for surgery or radiation or whose t...
Read MoreMedical and Surgical Management of Multifocal Superficial Basal Cell Carcinoma
May 2025 | Volume 24 | Issue 5 | Original Article | 483 | Copyright © May 2025
Background: Multifocal superficial basal cell carcinoma (sBCC) is a subtype of BCC characterized by subclinical extension of noncontiguous tumor islands and high recurrence rates...
Read MoreSquamous Cell Carcinoma In Situ on High-Risk Sites and With Larger Sizes Require More Stages for Clearance With Mohs Surgery
May 2025 | Volume 24 | Issue 5 | Original Article | 494 | Copyright © May 2025
Background: Few studies have evaluated Mohs micrographic surgery (MMS) for the treatment of squamous cell carcinoma in situ or evaluated the results by Mohs Appropriate Use Crite...
Read MoreEndocrine Mucin Producing Sweat Gland Carcinoma Treated With Mohs Micrographic Surgery: A Systematic Review
May 2025 | Volume 24 | Issue 5 | Original Article | 498 | Copyright © May 2025
Background: Endocrine Mucin Producing Sweat Gland Carcinoma (EMPSGC) is a low-grade, cutaneous adnexal neoplasm. It is believed to have a potential for local recurrence as well a...
Read MoreSynergistic Mechanisms of 5-Fluorouracil and Imiquimod in the Treatment of Actinic Keratoses
May 2025 | Volume 24 | Issue 5 | Editorials | e35 | Copyright © May 2025
Citation: Regester RM, Cannella AC, Thiele GM, et al. Synergistic mechanisms of 5-fluorouracil and imiquimod in the treatment of actinic keratoses. J Drugs Dermatol. 2025;24(5):e35....
Read MoreSurgical Outcomes of Cylindrocarcinoma Treated With Mohs Micrographic Surgery and Excision: A Systematic Review
May 2025 | Volume 24 | Issue 5 | Original Article | 444 | Copyright © May 2025
© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.
